Galina E. Chernukha

Galina E. Chernukha

Auto-generated profile, based on publicly available information

Galina E. Chernukha


Research Focus & Metrics

Academic Career Length

58Years (1969-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Fertility and Sterility
Verified
Journal Article
Closed access
DLDaria Lizneva
Daria Lizneva
RKRichard Kirubakaran
Richard Kirubakaran
KMKateryna Mykhalchenko
Kateryna Mykhalchenko
Larisa SuturinaLarisa Suturina
Larisa Suturina
GCGalina Chernukha
Galina Chernukha
RARicardo Azziz
Ricardo Azziz

Verified
Journal Article
Open access
PDF file
EKEvgenii Kukaev
Evgenii Kukaev
EKEkaterina Kirillova
Ekaterina Kirillova
ATAlisa Tokareva
Alisa Tokareva
ERElena Rimskaya
Elena Rimskaya
NSNatalia Starodubtseva
Natalia Starodubtseva
GSGennady T. Sukhikh
Gennady T. Sukhikh
Polycystic ovary syndrome (PCOS) is a complex disorder that impacts both the endocrine and metabolic systems, often resulting in infertility, obesity, insulin resistance, and cardiovascular complications. The aim of this study is to investigate the role of intestinal flora and its metabolites, particularly short-chain fatty acids (SCFAs), in the development of PCOS, and to assess the effects of metformin therapy on these components. SCFA levels in fecal and blood samples from women with PCOS (n=69) and healthy controls (n=18) were analyzed using Gas Chromatography–Mass Spectrometry (GC/MS) for precise measurement. Fecal microbiota were quantitatively detected by real-time polymerase chain reaction (PCR). To assess the efficacy of six months of metformin treatment, changes in the microbiota and SCFAs in the PCOS group (n=69) were also evaluated. The results revealed that women with PCOS exhibited a significant reduction in beneficial bacteria (namely, the C. leptum group and Prevotella spp.) alongside a notable overgrowth of opportunistic microorganisms (C. perfringens, C. difficile, Staphylococcus spp., and Streptococcus spp.). An overproduction of acetic acid (AA, FC=0.47, p<0.05) and valeric acid (VA, FC=0.54, p<0.05) suggests a link between elevated SCFAs and the development of obesity and PCOS. Interestingly, AA in the bloodstream might offer a protective effect against PCOS by ameliorating key symptoms such as high body mass index (r=−0.33, p=0.02), insulin resistance (r=−0.39, p=0.02), and chronic inflammation. Although serum SCFA levels showed non-significant changes following metformin treatment (p>0.05), the normalization of AA in the gut underscores that metformin exerts a more pronounced effect locally within the gastrointestinal tract. Furthermore, the study identified the most effective model for predicting the success of metformin therapy, based on serum concentrations of butyric acid (BA) and VA, achieving a 91% accuracy rate, 100% sensitivity, and 80% specificity. These promising findings highlight the potential for developing targeted interventions and personalized treatments, ultimately improving clinical outcomes for women with PCOS.

6 February 2022 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
LAL. V. Adamyan
L. V. Adamyan
EAE. N. Andreeva
E. N. Andreeva
YAYu. S. Absatarova
Yu. S. Absatarova
OGO. R. Grigoryan
O. R. Grigoryan
IDI. I. Dedov
I. I. Dedov
MYMaria Yarmolinskaya
Maria Yarmolinskaya
Polycystic ovary syndrome (PCOS) is a polygenic endocrine disorder caused by both genetic and epigenetic factors. Depending on the period of a woman’s life, the clinical picture, diagnosis, and treatment tactics of the disease are different. PCOS has a complex of reproductive, metabolic and psychological characteristics. The target audience of these clinical recommendations are obstetrician-gynecologists, endocrinologists, general practitioners, general practitioners. In these clinical guidelines, all information is ranked according to the level of persuasiveness of recommendations and the reliability of evidence, depending on the number and quality of studies on this issue.

1 September 2018 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
CCChernukha G.E. Chernukha
Chernukha G.E. Chernukha
Aleksandra AsaturovaAleksandra Asaturova
Aleksandra Asaturova
IIIvanov I.A. Ivanov
Ivanov I.A. Ivanov
DMDumanovskaya M.R. Dumanovskaya M
Dumanovskaya M.R. Dumanovskaya M

1 February 2005 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
GSG. T. Sukhikh
G. T. Sukhikh
AZAlexander V Zhdanov
Alexander V Zhdanov
MDM. P. Davydova
M. P. Davydova
TST. V. Slukina
T. V. Slukina
GCG. E. Chernukha
G. E. Chernukha
VSV. P. Smetnik
V. P. Smetnik

1 September 2003 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
AZAlexander V Zhdanov
Alexander V Zhdanov
GSG. T. Sukhikh
G. T. Sukhikh
MDM. P. Davydova
M. P. Davydova
TST. V. Slukina
T. V. Slukina
GCG. E. Chernukha
G. E. Chernukha
VSV. P. Smetnik
V. P. Smetnik